Member Info for Marmited

I am scratching my head.. the increase attributed to its LTF since Feb over at AVCT is 10 x current valuation of BRH in its entirety and yet that huge increase is based upon a test which still could fail, not gain a CE mark, not receive any orders.
If you are correct regarding BRH.. just how big is the bubble at AVCT?

So, by that logic? Can we expect a 243m increase here prior to CE mark and any details of manufacturing orders?

AVCT

Feb 15th £1.54p
March12th £2.50

That’s a 96p increase
253m shares in issue
£243m added to value of AVCT since Results of Initial Evaluation of SARS-CoV-2 Lateral Flow Antigen Test RNS Feb 16th.

A network of Optical Measurement Testing devices capable of digitally connecting to remote hubs on a national scale, removing the responsibility of the user to contact the test and trace program, a reusable testing device which is capable of identifying pre-current-post infectivity offering a super quick reliable testing method removing the need for a second PCR test, enabling a LIVE measurable difference to the progress of the pandemic will be come a system to replace current plastic disposable limited testing which are clearly inadequate.

My understanding is this final test is more about the quality of Aptamer’s Aptamer and the fluorescent coating abilities than the hardware of Paraytec.

I’m not a scientist, just to make that clear.

If the test can identify a single isolated intact Virion than yes, I take that to mean the person is infected. It’s measurement of sensitivity could be extremely close to 100%? using the probability of correctly identifying a sample with hundreds or thousands of virus particles. Post infectious state would contain virus fragments which many other tests may show as a false positive, but with this test only identifying intact Virions that must put an end to false positives?

Personally.. I’m extremely excited!

They have been tweaking it using an isolated single virion. If it is capable of identifying a single Virion than results should be incredible!

“In parallel to the sample processing described above, the Paraytec team has been using isolated lab-grown virus to optimise the operational sensitivity of its instrument for the detection of pre-symptomatic and early-stage symptomatic virus levels.”

Sensitivity and specificity. Oh. just how good this could be for so many things..

Paraytecs imaging, Carl Smythes’s fluorescence coating and Aptamers Aptamer

https://m.youtube.com/watch?v=FwJEAgwn6Uw

Sensitivity and specificity Data is key. They have a duty to release the results to the market as it will be price sensitive information. They have given a time period for when this data is due.

That’s ok. I think it reveals Aptamer’s ambition and self belief. Interestingly Paraytec now have a huge foot in the door at Board level of Aptamer..
Plan and plot thickens IMO.

Ha! You are funny! I did not write the article!..

APTAMER GROUP APPOINTS CHIEF OPERATING OFFICER

Aptamer Group, the York-based developer of diagnostic and therapeutic aptamer reagents, has appointed a new chief operating officer.
Mark Vaux has held senior and board level positions in engineering and high technology companies from start-ups to multinational organisations.
He has joined Aptamer Group from scientific instrument company Paraytec where he was chief executive.
Vaux is a chartered engineer and fellow of the Institution of Engineering and Technology.
Mark Vaux said: "I am delighted to join Aptamer Group, which is an innovative and ambitious company leading the way in its field. I have been involved in collaborative projects with the Aptamer team in the past and have always admired their capabilities.
"The scientists here are doing extraordinary work and I hope to bring my experience and skills to the mix to support them in the life-changing projects currently being undertaken by the business."

https://www.insidermedia.com/news/yorkshire/aptamer-group-appoints-chief-operating-officer

https://www.londonstockexchange.com/news-article/BRH/update-in-response-to-social-media-speculation/14529565?lang=en

Aptamer Group welcomed Rachael Maskell, MP for York Central, to its York Science Park premises to show its progress in developing a Covid-19 test that will generate results within seconds.

https://www.yorkpress.co.uk/news/18790622.aptamer-group-deserves-recognition-work-covid-19-test/

And to finish off, you clearly have an appetite for risky stock and that is fine. So, XTR valued at £55m? cough cough! And you challenge and belittle BRH holders? With an ownership of a device, the fastest, reusable, surpassing minimum MHRA requirements, potential to learn it may meet or surpass the current gold standard in a matter of 2 weeks or less, something the world is crying out for and currently valued at less than £25m (current cap.. as this company holds more interests than just Paraytec..) versus your investment in XTR? I cannot take you seriously!

Well I’m happily holding and will happily wait longer if your crystal ball is correct and it needs a little longer to fine tune the Rolls to ensure it purred along enabling it to smash current inadequate make do competition. Heck, silly me.. under 2 mins results and already capable of identifying an infectious viral load within the acceptable range specified by MHRA.
Could I wait longer to ensure the world has access to the accuracy of a PCR and the speed far superior to any antigen test? Hell yeah!
Stay out on the sidelines or hold.. frankly I don’t care and I doubt anyone here cares! Can I ask how long it took to build that pedestal? It’s huge!!
Both the above strategies are a risk. Get either wrong and you will either lose some wealth or lose out on wealth creation.

Well this is why I was bamboozled by the constant AVCT ramping. BRH is geared for large business premises, schools and colleges, hospitals, transport hubs etc etc where AVCT is geared for DIY home use, however, that type of device is being used in the above examples because alternatives such as BRH’s device are not available yet. Just my opinion.

The mathematical strategy that could transform coronavirus testing.

Four charts show how pooling samples from many people can save time or resources.

Old article but relevant.

https://www.nature.com/articles/d41586-020-02053-6

Looks to me that they are attempting to surpass current gold standard and put this into a new platinum league. ;-)

I’m wondering if we are missing a trick? Rather than seeing this as a COVID test system, perhaps a better opportunity is a post Pandemic Covid monitoring system?
International Travel, Workplace, educational, health services and vulnerable groups such as care homes will require continued tests twice a week after the opening up of society. Put this reusable device at each location and we have a very powerful national network possibly connected via 5G and extremely powerful for the Governments track and trace system.
Just a thought..

I think it will be a combination of many things with plenty of room for better LTF’s and Paraytecs technology.